Understanding bladder cancer risk: Mendelian randomization analysis of immune cell and inflammatory factor influence

Front Immunol. 2024 Oct 10:15:1460275. doi: 10.3389/fimmu.2024.1460275. eCollection 2024.

Abstract

Introduction: The intricate roles of immune cells and inflammatory factors in cancer, particularly their association with the risk of bladder cancer, are not well understood.

Methods: This study aimed to clarify potential causal relationships between these elements and the development of bladder cancer using genome-wide association study (GWAS) summary statistics for 731 immune cell phenotypes and 91 circulating inflammatory factors (cases=2,053; controls=287,137). The primary analytical approach was Inverse Variance Weighting (IVW), supplemented by MR-Egger regression, weighted median, and weighted mode analyses. Sensitivity analyses included Cochran Q test, MR-Egger intercept test, and Leave-one-out test.

Results: The findings indicated that monocytes are positively correlated with an increased risk of bladder cancer. On the contrary, double-negative (DN) T cells, HLA DR+CD8br, and CD28 on CD28+CD45RA+CD8br T cells exhibited an inverse correlation, suggesting a possible protective effect. Furthermore, inflammatory factors IL-20, IL-22RA1, and Eotaxin were significantly associated with an increased risk of bladder cancer.

Discussion: These results suggest that certain immune cell phenotypes and inflammatory factors may play a role in the development of bladder cancer and could serve as potential biomarkers for assessing tumor risk. The findings also offer new insights into the pathogenesis of bladder cancer, indicating a need for further investigation.

Keywords: GWAS; Mendelian randomization; bladder cancer; immune cell phenotypes; inflammatory factors.

MeSH terms

  • Genetic Predisposition to Disease
  • Genome-Wide Association Study*
  • Humans
  • Inflammation / genetics
  • Inflammation / immunology
  • Inflammation Mediators / metabolism
  • Mendelian Randomization Analysis*
  • Monocytes / immunology
  • Monocytes / metabolism
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Urinary Bladder Neoplasms* / genetics
  • Urinary Bladder Neoplasms* / immunology

Substances

  • Inflammation Mediators

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (82372056), the Guangzhou Municipal Science and Technology Project (2023A04J2217) and the Young Teacher Foundation of Sun Yat-sen University (23qnpy135).